BW LPG Signs MOA to Sell Two VLGCs to BW LPG India
BW LPG Limited ('BW LPG', OSE ticker code: 'BWLPG.OL', NYSE ticker code 'BWLP') has signed a Memorandum of Agreement (MOA) with BW LPG India to sell two vessels acquired in the recent Avance Gas transaction – BW Pampero and BW Chinook to BW LPG India (the 'transaction') at a price of approximately USD 75 million per vessel to ensure further expansion and fleet renewal in the Indian market. The delivery of the two vessels is expected in Q3 2025.
BW LPG India currently owns and operates India's largest fleet of Very Large Gas Carriers (VLGCs), comprising seven ships, after the recently announced sale of BW Cedar. The transaction will renew and grow the fleet and further enlarge BW LPG India's footprint in India. Taking over two vessels built in 2015 will not only result in fleet expansion but also in fleet renewal which comes at an opportune time with continued growth in India's LPG demand.
BW LPG India's fleet is Indian-flagged and Indian-operated to facilitate business transactions in alignment with the Atmanirbhar Bharat scheme (translated as self-reliant India). It is the youngest and largest fleet in India, accounting for import of approximately 20% of LPG into India.
BW LPG India was established as a joint venture in 2017 between BW LPG Limited and Global United Shipping and is headquartered in Chennai. In 2021, Maas Capital Shipping B.V. acquired a minority stake of 42% in BW LPG India, with BW LPG currently holding 52% of the shares.
Mr. Kristian Sørensen, CEO of BW LPG, adds: 'With BW Pampero and BW Chinook we add modern quality tonnage and more capacity to our Indian-flagged fleet. We see tremendous potential in the country and are proud to participate in the continued growth of the Indian LPG market. We would like to thank our partners, Mass Capital and Global United Shipping, for their trust and collaboration, and for partaking in sustained fleet renewal.'
The transaction of BW Pampero and BW Chinook reflects BW LPG's strategy to right-size and renew its fleet in growing markets. BW LPG leverages on its strong commercial platform and continues to grow its Indian fleet to support the country's energy transition while weathering any geopolitical uncertainties.
About BW LPG
BW LPG is the world's leading owner and operator of LPG vessels, owning and operating Very Large Gas Carriers (VLGC) with a total carrying capacity of over 4 million CBM. With five decades of operating experience in LPG shipping and experienced seafarers and staff, BW LPG offers a flexible and reliable service to customers. More information about BW LPG can be found at www.bwlpg.com.
BW LPG is associated with BW Group, a leading global maritime company involved in shipping, floating infrastructure, deepwater oil & gas production, and new sustainable technologies. Founded in 1955 by Sir YK Pao, BW controls a fleet of over 490 vessels transporting oil, gas and dry commodities, with its 200 LNG and LPG ships constituting the largest gas fleet in the world. In the renewables space, the group has investments in solar, wind, batteries, biofuels and water treatment.
INDUSTRY KEYWORD: OIL/GAS ENERGY MARITIME LOGISTICS/SUPPLY CHAIN MANAGEMENT TRANSPORT
SOURCE: BW LPG Limited
Copyright Business Wire 2025.
PUB: 03/31/2025 01:10 AM/DISC: 03/31/2025 01:10 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
32 minutes ago
- Business Upturn
Nomura upbeat on Dr. Reddy's long-term prospects; maintains ‘Buy' call with Rs 1,575 target
By Markets Desk Published on June 12, 2025, 07:38 IST Nomura has maintained its Buy rating on Dr. Reddy's Laboratories, setting a target price of ₹1,575, following the company's strategic roadmap shared during a recent management interaction. The company laid out four key levers to sustain growth and profitability beyond the gRevlimid opportunity, including: Sustained growth in the base business, Significant upside potential from semaglutide, the blockbuster diabetes and weight-loss drug, Capacity to undertake selective acquisitions in the $2–2.5 billion range, and A strong focus on cost rationalisation, with plans to reduce operating expenses by 500 basis points — from 37% to 32% of sales — thereby maintaining EBITDA margins around 25%. Dr. Reddy's, a major Indian pharmaceutical company with a strong global presence, has expanded its footprint across generics, biosimilars, and active pharmaceutical ingredients (APIs). It has also been building its presence in high-value markets like the US, Europe, and emerging markets through a mix of organic growth and strategic deals. Nomura believes the combination of margin optimisation, pipeline monetisation (including complex generics like semaglutide), and balance sheet flexibility places the company in a strong position for long-term value creation. Disclaimer: The views and target prices mentioned are as stated by Nomura and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
Business Upturn
32 minutes ago
- Business Upturn
Jefferies bullish on real estate pre-sales; sees rate cuts boosting mid-income housing
By Markets Desk Published on June 12, 2025, 07:49 IST Jefferies has turned increasingly constructive on the Indian real estate sector, expecting pre-sales growth for listed developers to rise over 20% in FY26, up from 15% in FY25. The brokerage cited strong project launch activity in Q1FY26, which lends credibility to developer guidance, contrasting the patchy execution seen last year. It further noted that the recent rate cuts by the RBI are a relief for the mid-income and affordable housing segments, improving affordability and mortgage flow. Despite the sharp rally in property stocks over the past year, Jefferies pointed out that most names continue to trade in line with their 5-year NAV premiums, leaving room for re-rating if visible sales growth persists. Top picks include DLF, Godrej Properties (GPL), and Lodha (Macrotech Developers). Disclaimer: The views and target prices mentioned are as stated by Jefferies and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
Business Upturn
33 minutes ago
- Business Upturn
HSBC sees quicker NIM normalisation for Indian banks after repo rate, deposit rate cuts
By Markets Desk Published on June 12, 2025, 07:48 IST HSBC believes that Indian banks could witness faster-than-expected normalisation in Net Interest Margins (NIMs) following the Reserve Bank of India's upfront repo rate cut and anticipated reductions in deposit rates. According to the brokerage, high deposit beta — the tendency of deposit rates to follow policy rates — will support meaningful easing in cost of funds for lenders. HSBC estimates that deposit rate cuts could lower costs by 24–60 basis points for private sector banks and by 11–24 basis points for public sector banks over the next 12 months. In terms of beneficiaries, HSBC believes smaller and mid-sized banks will gain the most, followed by large private banks, with PSU banks benefitting at the margin. This outlook comes at a time when banks have started to reprice deposits downward, and expectations of further rate transmission are increasing. HSBC suggests that this could support margin stability even in a softening interest rate environment. Disclaimer: The views and target prices mentioned are as stated by HSBC and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
